1. Home
  2. PTIX vs AKAN Comparison

PTIX vs AKAN Comparison

Compare PTIX & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagenic Therapeutics Inc.

PTIX

Protagenic Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

3.2M

Sector

Health Care

ML Signal

HOLD

Logo Akanda Corp.

AKAN

Akanda Corp.

HOLD

Current Price

$0.92

Market Cap

1.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTIX
AKAN
Founded
1994
2021
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
1.6M
IPO Year
2016
2022

Fundamental Metrics

Financial Performance
Metric
PTIX
AKAN
Price
$1.66
$0.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
103.8K
5.5M
Earning Date
11-26-2025
12-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$836,664.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
183.67
52 Week Low
$1.46
$0.74
52 Week High
$14.28
$9.29

Technical Indicators

Market Signals
Indicator
PTIX
AKAN
Relative Strength Index (RSI) 33.67 35.40
Support Level $1.46 $0.74
Resistance Level $1.70 $1.34
Average True Range (ATR) 0.18 0.15
MACD -0.00 0.03
Stochastic Oscillator 20.65 28.67

Price Performance

Historical Comparison
PTIX
AKAN

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About AKAN Akanda Corp.

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.

Share on Social Networks: